BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Relypsa, Inc. 

5301 Patrick Henry Drive

Santa Clara  California  95054  U.S.A.
Phone: 408-200-9500 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Relypsa, Inc. (RLYP) To Be Added To NASDAQ Biotechnology Index 12/17/2014 7:42:27 AM
Relypsa, Inc. (RLYP) Announces Stephen D. Harrison, M.A., Ph.D., Joins As Senior Vice President And Chief Scientific Officer 12/16/2014 7:50:59 AM
Relypsa, Inc. (RLYP) Announces FDA Acceptance Of New Drug Application For Patiromer For Oral Suspension To Treat Hyperkalemia 12/15/2014 7:23:13 AM
Relypsa, Inc. (RLYP) To Present At Oppenheimer 25th Annual Healthcare Conference 12/5/2014 10:56:48 AM
Relypsa, Inc. (RLYP) Announces New Employment Inducement Grants 11/21/2014 2:50:12 PM
Relypsa, Inc. (RLYP) Announces Data Published In The New England Journal of Medicine For Pivotal Phase 3 Program Of Patiromer FOS For The Treatment Of Hyperkalemia 11/21/2014 11:20:05 AM
Relypsa, Inc. (RLYP) Announces Key Data Presented At American Society of Nephrology On Long-Term Chronic Treatment And Early Onset Of Action With Patiromer For Oral Suspension 11/17/2014 2:06:07 PM
Relypsa, Inc. (RLYP) To Present At Stifel Healthcare Conference 11/12/2014 10:18:34 AM
Relypsa, Inc. (RLYP) Announces Launch Of Educational Website To Advance U.S. Physicians' Awareness And Understanding Of Hyperkalemia 11/6/2014 1:10:51 PM
Relypsa, Inc. (RLYP) Announces Multiple Patiromer For Oral Suspension Abstracts To Be Presented At American Society of Nephrology Annual Meeting 2014 11/4/2014 7:46:05 AM
1234567